GL1X · GenesisL1 explorer

Research workbench

Crystallographic studies on two bioisosteric analogues, N-acetyl-beta- D-glucopyranosylamine and N-trifluoroacetyl-beta-D- glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase

Analyse Crystallographic studies on two bioisosteric analogues, N-acetyl-beta… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1WW3
Type
protein
Length
809 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
NTF, PLP
Pockets
13 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein80952% helix, 15% strandP00489

Ligands and binding sites

  • NTF · N-(trifluoroacetyl)-beta-D-glucopyranosylamine · ligand · chains A
  • PLP · Pyridoxal-5'-phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13220.850.9557NTF, PLP
22600.660.8332empty
32600.650.8248empty
41150.530.8219empty
52210.510.7620empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1WW3 · Crystallographic studies on two bioisosteric analogues… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.